Detalhe da pesquisa
1.
Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis.
Nat Commun
; 14(1): 3631, 2023 06 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37336877